Karyopharm Therapeut (KPTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -72,114 | -38,459 | -128,984 | -89,944 | -59,304 |
| Depreciation Amortization | 623 | 329 | 1,900 | 1,442 | 955 |
| Accounts payable and accrued liabilities | -1,870 | -773 | 909 | -2,867 | -1,507 |
| Other Working Capital | -9,393 | -686 | 32,962 | 4,417 | 882 |
| Other Operating Activity | 10,474 | 4,937 | 19,496 | 18,773 | 12,545 |
| Operating Cash Flow | $-72,280 | $-34,652 | $-73,717 | $-68,179 | $-46,429 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -779 | -382 | -62 | -7 | N/A |
| Purchase Of Investment | -74,943 | -24,736 | -98,374 | -74,017 | -61,564 |
| Sale Of Investment | 50,602 | 27,602 | 115,544 | 94,033 | 60,979 |
| Investing Cash Flow | $-25,120 | $2,484 | $17,108 | $20,009 | $-585 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 147,561 | 429 | 75,743 | 52,786 | 52,626 |
| Financing Cash Flow | $147,561 | $429 | $75,743 | $52,786 | $52,626 |
| Exchange Rate Effect | -44 | 43 | 211 | 181 | 111 |
| Beginning Cash Position | 69,487 | 69,487 | 50,142 | 50,142 | 50,142 |
| End Cash Position | 119,604 | 37,791 | 69,487 | 54,939 | 55,865 |
| Net Cash Flow | $50,117 | $-31,696 | $19,345 | $4,797 | $5,723 |
| Free Cash Flow | |||||
| Operating Cash Flow | -72,280 | -34,652 | -73,717 | -68,179 | -46,429 |
| Capital Expenditure | -779 | -382 | -62 | -7 | N/A |
| Free Cash Flow | -73,059 | -35,034 | -73,779 | -68,186 | -46,429 |